- China is reportedly investigating Sanofi (NASDAQ:SNY) for allegedly paying bribes of 1.7M yuan ($277,600) to over 500 Chinese doctors in order to increase sales.
- The probe follows a report on Thursday in which a whistleblower accused the French pharmaceuticals company of making the payments.
- The inquiry also comes as authorities investigate GSK for bribery and amid visits to other foreign drug companies, including Novo Nordisk, AstraZeneca and Eli Lilly.